PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VE

A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases. La présente invention co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHU, YONGHONG, BAI, XIAOLIN, SUN, HE, ZHANG, SHUNNAN, YAN, KAIJING, HE, YI, MA, XIAOHUI, LI, TING, YAN, XIJUN, LI, LEI, WU, NAIFENG
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases. La présente invention concerne une composition pharmaceutique préparée à partir des matières premières suivantes (en parties en poids) : silybine (8,75-60), phospholipide (15-65), extrait de thé Pu'er (25-200), et vitamine E (6,25-40). La composition permet le traitement de stéatoses non alcooliques.